RxDoctor Payments Data

Adam-Paul Langlinais

Surgical · Lafayette, LANPI 1437308202

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 86.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $1,554 and has fallen 82.7% since, to $269 in 2025. Among surgical clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,038in general payments, 2019–2025

Across 74 payments — averaging $68.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Globus Medical$197
  • Abiomed$168
  • Shockwave Medical, Inc$163
  • Philips North America LLC$74
  • Cardiva Medical, Inc.$70

What the payments were for

  • Food & beverage$5,038100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,038 in reported general payments places this provider in the 90th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$23,964
Medicare patients
106
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$4,682
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen98$769
Amiodarone Hcl59$611
Valsartan19$493
Metoprolol Tartrate74$303
Atorvastatin Calcium20$253
Oxycodone Hcl35$197
Metoprolol Succinate17$176
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$165
ClopidogrelClopidogrel Bisulfate23$108
Furosemide18$23

Paid to pharmacies, not to this prescriber.

Other surgical in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →